Nephros NEPH
NASDAQ NEPH
$3.71 +0.00 (+0.00%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nephros (NEPH) Research & Development (2010 - 2026)

Updated

Nephros (NEPH) reported Research & Development of $366,000 for Q2 2026, up 17.7% from $311,000 a year earlier and up 5.8% from the prior quarter.

Analysis

Nephros (NEPH) Research & Development (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nephros' Research & Development came in at $1.45 million, up 38.1% year-over-year; for FY2025, it came in at $1.34 million, up 47.8% from FY2024.

  • Research & Development has a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
  • By year, Research & Development came in at $906,000 in FY2024 (+3.8%), $873,000 in FY2023 (-30.4%), $1.26 million in FY2022 (-16.2%) and $1.5 million in FY2021 (-45.7%).
  • Five-year quarterly Research & Development spans a low of $188,000 in Q3 2024 and a high of $395,000 in Q4 2025.
  • Year over year, Research & Development has now increased in each of the last seven quarters, with growth averaging 30.7% over the last eight quarters.
  • The high point for year-over-year Research & Development in five years was Q3 2025 (growth of 79.8%); the low point was Q3 2021 (a decline of 47.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $346,000 (Q1 2026), $395,000 (Q4 2025) and $338,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 892.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 370.60 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 771.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 554.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 278.90 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 258.00 Mn
10 Nephros 40.29 Mn 21.01 Mn 4.03 Mn 366,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 366,000.00
Mar 31, 2026 346,000.00
Dec 31, 2025 395,000.00
Sep 30, 2025 338,000.00
Jun 30, 2025 311,000.00
Mar 31, 2025 295,000.00
Dec 31, 2024 252,000.00
Sep 30, 2024 188,000.00
Jun 30, 2024 254,000.00
Mar 31, 2024 212,000.00
Dec 31, 2023 208,000.00
Sep 30, 2023 205,000.00
Jun 30, 2023 221,000.00
Mar 31, 2023 239,000.00
Dec 31, 2022 359,000.00
Sep 30, 2022 252,000.00
Jun 30, 2022 273,000.00
Mar 31, 2022 372,000.00
Dec 31, 2021 328,000.00
Sep 30, 2021 395,000.00
API Access

Nephros Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=NEPH&period=max&api_key=YOUR_API_KEY